Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 15/20 | 0.67 |
| ▸ | PPARG | P37231 | 14/20 | 0.67 |
| ▸ | PPARD | Q03181 | 13/20 | 0.67 |
| ▸ | EPHX2 | P34913 | 5/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5345778 | 0.87 | PPARG (0.69) | PPARAPPARGPPARDEPHX2 | |
| SCHEMBL3945192 | 0.81 | PPARA (1.00) | PPARAPPARGPPARDEPHX2 | |
| SCHEMBL3945228 | 0.80 | PPARD (0.82) | PPARAPPARGPPARDEPHX2 | |
| SCHEMBL5350230 | 0.78 | PPARA (0.80) | PPARAPPARGPPARD | |
| SCHEMBL5362876 | 0.77 | PPARA (0.83) | PPARAPPARGPPARDEPHX2 | |
| SCHEMBL3945781 | 0.76 | PPARA (1.00) | PPARAPPARGPPARD | |
| SCHEMBL6505382 | 0.73 | PPARA (0.81) | PPARAPPARGPPARD | |
| SCHEMBL6496409 | 0.73 | PPARA (0.70) | PPARAPPARGPPARD | |
| SCHEMBL6503458 | 0.71 | PPARA (0.52) | PPARAPPARGPPARDEPHX2 | |
| SCHEMBL3943372 | 0.71 | PPARD (1.00) | PPARAPPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7176204-B2 | Substituted carboxylic acid derivatives | KYORIN PAHRMACEUTICAL CO., LTD. (JP) | 2007-02-13 | — | — | US | disclosed |
| US-7176204-B2 | Substituted carboxylic acid derivatives | KYORIN PAHRMACEUTICAL CO., LTD. (JP) | 2007-02-13 | — | — | US | disclosed |
| US-7176204-B2 | Substituted carboxylic acid derivatives | KYORIN PAHRMACEUTICAL CO., LTD. (JP) | 2007-02-13 | — | — | US | disclosed |
| US-20050101521-A1 | Substituted carboxylic acid derivatives | KYORIN PHARMACEUTICAL CO., LTD. (JP) | 2005-05-12 | — | — | US | disclosed |
| EP-1348698-A1 | SUBSTITUTED CARBOXYLIC ACID DERIVATIVES | Kyorin Pharmaceutical Co., Ltd. (JP) | 2003-10-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050101521-A1 | Substituted carboxylic acid derivatives | PPARG, PPARA, PPARD | PPARA 2/4885PPARG 1/4885PPARD 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.